Clinical Trial Update: Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating the use of tacrolimus and mycophenolate mofetil to prevent graft-versus-host disease in patients undergoing total-body irradiati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Cancer

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Phase 2 | Status: COMPLETED | Results posted: 2017-05-22